Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marsden

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Clinical and Experimental Dermatology|May 12, 2010
Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centreR Rajaratnam, C Mann, P Balasubramaniam, et al.
The Journal of Pathology|April 1, 1994
Classification of CEA-related positivity in primary and metastatic malignant melanomaD S Sanders, A T Evans, C A Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanomaB W Hancock, K Wheatley, S Harris, et al.
The British Journal of Dermatology|July 9, 2010
Revised U.K. guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Gene Therapy|February 11, 2011
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaJ C Steele, A Rao, J R Marsden, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
The British Journal of Dermatology|November 5, 2020
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020S G Keohane, J Botting, P G Budny, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Clinical and Experimental Dermatology|May 12, 2010
Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centreR Rajaratnam, C Mann, P Balasubramaniam, et al.
The Journal of Pathology|April 1, 1994
Classification of CEA-related positivity in primary and metastatic malignant melanomaD S Sanders, A T Evans, C A Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanomaB W Hancock, K Wheatley, S Harris, et al.
The British Journal of Dermatology|July 9, 2010
Revised U.K. guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Gene Therapy|February 11, 2011
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaJ C Steele, A Rao, J R Marsden, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
The British Journal of Dermatology|November 5, 2020
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020S G Keohane, J Botting, P G Budny, et al.
Pageof 7